查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1861978

骨水泥和骨黏合剂市场按产品类型、应用、最终用户、技术和分销管道划分－2025-2032年全球预测

Bone Cement & Glue Market by Product Type, Application, End User, Technology, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，骨水泥和黏合剂市场将成长至 32.9 亿美元，复合年增长率为 6.56%。

关键市场统计数据
基准年 2024 19.8亿美元
预计年份：2025年 21.1亿美元
预测年份 2032 32.9亿美元
复合年增长率 (%) 6.56%

清楚地介绍了生物材料创新和不断发展的临床工作流程如何重新定义骨水泥和外科黏合剂的选择。

随着生物材料技术的进步与外科手术流程的不断演进，骨水泥和黏合剂领域正吸引临床、监管和商业相关人员的广泛关注。本报告首先对骨水泥和黏合剂在现代整形外科、颅颜外科、牙科和脊椎外科治疗路径中的地位进行概述，并阐明其成分、剂型和最终用户环境的差异如何影响其应用和临床疗效。

临床团队越来越倾向于选择兼具操作性能和生物活性的材料。因此，该领域的产品组合正从传统的聚甲基丙烯酸甲酯（PMMA）基水泥扩展到旨在促进组织整合或局部给药的新型生物活性材料。同时，随着集团采购组织、竞标主导的医院合约以及与优先考虑长期价值和供应稳定性的製造商直接交易的兴起，分销和采购模式也在进行重组。

从采购方的观点来看，技术选择受手术复杂程度、设施容量和报销趋势的影响，导致医院手术室、门诊手术中心和专科诊所的采用率存在差异。因此，相关人员不仅要根据关键绩效指标评估产品系列，还要考虑灭菌、储存以及与术中工作流程的兼容性。本导言概述了这些趋势，并为后续的详细分析奠定了基础。

生物材料的进步、手术流程向门诊转移以及监管要求的提高将如何重塑市场动态和临床应用？

过去几年，材料科学的突破、外科手术技术的革新以及监管力度的加大，彻底改变了骨水泥和外科黏合剂的竞争格局和临床应用现状。生物活性配方的创新已从概念验证发展到常规临床评估阶段，使得促进骨整合和实现可控吸收特性的材料成为可能。同时，注射型和可塑型等给药方式的改进，也扩大了这些产品在微创和门诊手术的应用范围。

同时，成本控制压力和缩短住院时间的趋势导致某些手术逐渐从住院机构转移到门诊手术中心和专科诊所。这种转变迫使供应商改善包装、灭菌和操作特性，以适应低风险环境，因为这些场所的空间和设备与传统的手术室环境不同。手术施行地点的转移也凸显了产品易用性和在有限时限内可预测的性能的重要性。

监管要求也在不断提高，特别是对含抗菌药物产品的安全性标籤要求以及支持长期治疗效果的临床数据。因此，各公司正大幅增加对临床证据产生和上市后监测的投入。材料创新、不断变化的治疗环境以及监管的加强，共同提高了市场准入和持续商业性成功的门槛，同时也为企业开闢了新的差异化竞争途径。

评估近期关税如何促使各产业进行策略性供应链重组、采购区域化和商业合约转型。

2025年关税的实施和贸易政策的变化，标誌着骨水泥和骨接合剂产业的供应链策略迎来了一个明显的转折点。中间投入品和成品的进口关税增加了依赖跨境生产聚合物、活性添加剂和包装材料的製造商的到岸成本。为此，各公司正在重新评估筹资策略，同时加快生产能力的区域化，以降低关税波动带来的风险，并确保向关键临床客户按时交付产品。

随着原物料成本上涨，采购部门越来越重视以价值基本契约和长期供应协议，以锁定价格和服务水准。这促使他们与经销商和集团采购组织进行更多谈判，而这些组织本身也在调整供应商组合，优先选择拥有稳定近岸生产基地的製造商。因此，那些製造地不多元化或依赖单一供应商的公司，要么被迫寻找替代供应商，要么投资建立本地生产能力。

关税环境也在推动包装和产品设计方面的创新，以优化运输效率并降低基于重量和体积的关税。同时，企业正在加快与区域合作伙伴进行契约製造和授权合作，以规避某些贸易壁垒，同时保持市场连续性。这些战略应对措施并非简单的战术性成本削减措施，而是影响竞争地位、新配方上市时间以及供应链在不断变化的贸易政策下韧性的长期决策。

详细的細項分析揭示了产品化学成分、临床应用、终端用户环境、技术类型和分销选择如何驱动不同的采用路径。

细分市场分析揭示了产品化学成分、临床应用、终端用户环境、技术等级和分销模式等方面的细微性能特征和应用路径差异。按产品类型划分，市场由丙烯酸骨水泥和磷酸钙骨水泥组成。丙烯酸骨水泥又可分为含抗生素配方（用于满足感染控制通讯协定）和不含抗生素配方（用于满足标准固定需求）。同时，磷酸钙骨水泥则提供注射型和可塑性两种形式，以满足微创给药和术中塑形需求。

从应用角度来看，临床需求分布在颅颚颜面外科、口腔科和整形外科等多个专科。颅颚颜面的适应症主要集中在重组手术和创伤修復，尤其註重轮廓恢復和固定。口腔科的应用涵盖植入和修復手术，其中生物相容性和可操作性会影响骨整合。整形外科的应用包括骨折固定、关节重建和脊椎手术，每种手术都有其独特的机械和生物性能要求，这些要求会影响材料的选择。

终端用户的需求差异显着。包括多专科中心和整形外科中心在内的门诊手术中心，优先考虑快速治疗、易于操作以及能够提升处理效率的价值体系。同时，公立和私立医院则需要能够应对复杂手术且符合机构采购通讯协定的多功能性。包括牙科诊所和门诊復健中心在内的专科诊所，则需要小包装和易于使用的配送系统，以满足高频次的门诊工作流程。

技术细分区分了生物活性方法和基于PMMA的平台。生物活性技术包括磷酸钙和硅酸钙等，旨在与活体组织相互作用并促进癒合。另一方面，基于PMMA的解决方案提供高黏度和低黏度两种选择，这些黏度因其机械稳定性和操作性能而被选中。从分销角度来看，透过OEM合作关係或竞标合约进行直接销售非常适合大型机构客户。同时，经销商透过集团采购组织或独立管道触达更广泛的基本客群，而由电子商务平台和製造商网站组成的线上管道对于小批量采购者和需要快速补货的客户而言正变得越来越重要。这些细分维度共同构成了一个需求讯号矩阵，製造商和供应商必须解读这些讯号，才能有效调整其产品开发、行销和销售策略。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势将影响招聘趋势、监管重点和供应策略。

区域趋势对商业化策略和产品开发重点均有显着影响。在美洲，成熟的医院基础设施、广泛的私立医院网络以及不断扩展的门诊手术能力正在塑造市场需求趋势，这些因素共同为成熟的PMMA基产品以及新兴的、用于控制感染和促进骨整合的生物活性配方创造了机会。该地区成熟的采购模式正在推动建立长期的供应商关係和结构化的合约机制，这些机制重视基于实证的绩效和可靠的供应链。

在欧洲、中东和非洲地区，监管协调和多样化的医疗模式造就了错综复杂的市场接受度曲线。西欧市场需要严谨的临床数据，并且通常是先进生物活性材料应用的中心；而该地区的其他市场则可能更注重成本效益和供应链的适应性。新兴市场在基础设施投资和外科手术服务覆盖范围扩大的推动下，展现出巨大的成长潜力，但同时也需要客製化的分销策略和灵活的定价结构。

亚太地区的市场成熟度差异显着，大型都市区医疗中心采用先进的材料和输送系统，而农村地区则更注重价格实惠和使用便利。多个国家的在地化生产基地和充满活力的医疗技术创新生态系统正在加速产品在地化和客製化进程。在整个亚太地区，供应链韧性、监管完整性以及展现临床和经济价值的能力仍然是产品持续应用和市场渗透的关键因素。

竞争格局概述，展示了现有企业、专业创新者和通路合作伙伴如何塑造产品差异化和市场进入策略。

骨水泥和外科黏合剂领域的竞争动态由成熟製造商、特种生医材料公司、契约製造以及专注于下一代生物活性化学物质的创新Start-Ups共同构成。成熟企业受益于与大型医院系统的牢固关係、广泛的商业性布局以及在多个司法管辖区获得监管核准的经验。这些企业利用规模经济优化生产成本，投资于临床证据开发，并经常提供包含仪器和培训在内的捆绑式解决方案。

同时，中型和新兴企业正透过专注于利基技术来实现差异化竞争，例如具有复杂洗脱特性的抗生素浸渍骨水泥、专为特定整形外科领域设计的磷酸钙基产品，以及能够减少术中变异性的精准输送平台。契约製造组织（CMO）正发挥日益重要的策略作用，它们帮助规模较小的创新企业管理品管系统和法规遵从性，同时扩大生产规模。

经销合作伙伴，包括全国性经销商和集团采购组织，是医院处方笺集和门诊网路的安全隔离网闸。他们对采购决策的影响凸显了通路策略的重要性，该策略需要平衡直接销售关係和广泛的分销协议。随着产品上市速度和遵守当地法规成为优先事项，伙伴关係和授权模式也变得十分普遍。整体而言，竞争优势取决于公司展现临床差异化、维持供应连续性以及与采购、临床试验点和医院经营团队等相关人员保持良好关係的能力。

在不断变化的医疗保健环境中，製造商和供应商应采取切实可行的策略重点，以增强临床差异化、供应链韧性和商业性扩充性。

骨水泥和骨接合剂领域的领导企业应采取多管齐下的策略，兼顾产品卓越性、供应链韧性以及与不断发展的临床路径的契合。首先，他们应投资于临床证据项目，这些项目不仅要满足监管要求，还要产生真实世界的结果数据，以证明感染率降低、植入稳定性提高以及患者康復时间缩短。这些数据有助于在采购谈判中形成差异化的价值提案，并推动产品进入医院处方集和优选供应商名单。

其次，我们正在实现製造地和采购基础多元化，以降低贸易政策风险，并确保对关键医院客户的持续供应。这包括发展区域製造伙伴关係、委託製造协议，以及选择性地进行近岸外包，以缩短前置作业时间和降低关税风险。同时，我们也在优化包装和物流，以最大限度地降低运输成本，并满足门诊环境的特殊需求，因为门诊的空间和设备与传统手术室有所不同。

第三，优化您的商业模式，平衡直销、经销商伙伴关係和数位化通路。虽然与大型机构买家直接合作对于复杂的产品仍然至关重要，但经销商和线上平台可以帮助您拓展客户群体，涵盖规模较小的诊所和牙科诊疗机构。此外，优先考虑能够简化产品操作并展示流程效率的培训和教育项目。临床医师重视能够减少术中不确定性的实务支持和实证通讯协定。

最后，我们将推动以使用者为中心的产品功能研发，例如可调节的设定时间、更高的渗透性和相容的输送工具。产品开发将与策略联盟结合，以加速临床检验和监管核准。这些措施的全面实施将巩固我们的市场地位，并在临床和采购环境不断变化的情况下，打造永续的竞争优势。

结合临床医生访谈、供应商文件分析和多方面资料检验的稳健混合调查方法确保了研究的实用性和严谨性。

本分析所依据的研究融合了定性和定量方法，以确保获得全面且基于证据的见解。主要研究包括对整形外科、颅颜外科和牙科临床医生、医院和门诊手术中心的采购主管、生物材料製造商的产品经理以及分销主管进行结构化访谈。这些访谈直接揭示了影响产品选择的临床性能预期、采购决策驱动因素和营运限制。

二次研究包括对同行评审文献、监管指导文件和已发表的临床研究摘要系统性回顾，以检验材料特性、性能声明和安全性概况。此外，还分析了供应商文件、产品说明书和临床技术指南，以评估操作特性和使用通讯协定。资料三角验证法整合了来自一手访谈和二级资讯来源的发现，以识别共同的主题并调和相互衝突的观点。

分析方法包括对定性访谈记录进行主题编码、跨产品类型和技术进行比较特征映射，以及情境分析以评估供应链中断和政策变化的影响。品质保证流程包括与多位受访者进行交叉检验、由领域专家对研究结果草稿进行同行评审，以及遵守资料来源和方法论假设的透明文件标准。这种严谨的方法论为相关人员提供了既具有实务意义又具有分析严谨性的研究结果，可供其在策略和营运规划中使用。

策略概述重点在于临床表现、采购重点和供应链韧性的整合，以定义未来的市场领导

总而言之，骨水泥和外科黏合剂市场正朝着兼具可靠机械性能、生物活性和在各种手术环境中易于操作的解决方案转型。这项转变的驱动力来自临床对改善治疗效果的需求、强调价值和供应稳定性的采购压力，以及优先考虑病人安全和实证实践的监管要求。将产品开发与临床工作流程结合，并投资于扩充性、在地化且具弹性的供应模式的相关人员，将更有利于把握新的机会。

随着产业发展，成功将越来越取决于能否将材料科学转化为可操作的临床效益（例如降低感染风险、改善固定效果、加速病患復原），同时也要应对分销和采购方面的复杂性。在设计阶段早期就让临床医生参与其中，与区域製造商和契约製造製造商合作以确保供应，并采用数据驱动的价值提案，这种协作方式将使供应商在竞争激烈的市场中脱颖而出。总而言之，那些将成熟的临床价值与卓越的营运和策略灵活性相结合的公司前景光明。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 用于关节重建手术感染预防的含抗生素PMMA骨水泥配方迅速增加
  • 开发一种完全可生物降解的磷酸钙骨接合剂，能够实现骨骼随时间推移的完全再生。
  • 将干细胞载体整合到生物活性骨黏附基质中，以促进术后局部组织癒合
  • 采用结合光固化和化学固化的双重固化牙科黏合剂，提高了黏合耐久性。
  • 扩大兽用骨水泥在伴侣动物骨折修復手术的应用范围
  • 在整形外科手术中，利用3D列印技术製作患者特异性骨水泥模具，用于复杂的植入几何形状。
  • 透过聚合物化学家和骨科医生的合作，开发出一种热敏性可注射骨接合剂

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的骨水泥和骨黏合剂市场

  • 丙烯酸骨水泥
    • 含有抗生素
    • 不含抗生素
  • 磷酸钙水泥
    • 射出模具
    • 可塑性型

9. 按应用分類的骨水泥和骨黏合剂市场

  • 颅颚颜面外科
    • 重组手术
    • 创伤修復
  • 牙科
    • 植入
    • 维修
  • 整形外科
    • 骨折固定
    • 关节重建
    • 脊椎手术

第十章 依最终用户分類的骨水泥和骨黏合剂市场

  • 门诊手术中心
    • 多专科医疗机构
    • 整形外科中心
  • 医院
    • 私立医院
    • 公立医院
  • 专科诊所
    • 牙医诊所
    • 门诊復健

第十一章 依技术分類的骨水泥和骨黏合剂市场

  • 生物活性
    • 磷酸钙
    • 硅酸钙
  • PMMA基材
    • 高黏度
    • 低黏度

第十二章 骨水泥和骨黏合剂市场（依通路划分）

  • 直销
    • 原厂设备製造商
    • 竞标合约
  • 经销商
    • 集团采购组织
    • 独立经销商
  • 线上管道
    • 电子商务平台
    • 製造商官方网站

第十三章 骨水泥和骨黏合剂市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 骨水泥和骨黏合剂市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国骨水泥和骨黏合剂市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Zimmer Biomet Holdings, Inc.
    • Stryker Corporation
    • DePuy Synthes, Inc.
    • Heraeus Medical GmbH
    • Smith & Nephew plc
    • B. Braun Melsungen AG
    • Medtronic plc
    • TEI Biosciences, Inc.
    • DJO Global, Inc.
    • Paragon 28, LLC
Product Code: MRR-521BAA36EADE

The Bone Cement & Glue Market is projected to grow by USD 3.29 billion at a CAGR of 6.56% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.98 billion
Estimated Year [2025] USD 2.11 billion
Forecast Year [2032] USD 3.29 billion
CAGR (%) 6.56%

A clarifying introduction to how biomaterial innovation and clinical workflow evolution are redefining bone cement and surgical adhesive selection

The bone cement and adhesive landscape is experiencing heightened attention from clinical, regulatory, and commercial stakeholders as advances in biomaterials converge with evolving surgical workflows. This report opens with an oriented introduction that situates bone cement and glue within contemporary orthopedic, craniofacial, dental, and spinal care pathways, clarifying how variations in composition, delivery formats, and end-user settings influence adoption and clinical outcomes.

Clinical teams increasingly demand materials that balance handling characteristics with biological performance. Consequently, the sector's product mix now spans traditional polymethyl methacrylate (PMMA)-based cements and newer bioactive chemistries designed to support tissue integration or deliver localized therapeutics. Meanwhile, distribution and procurement models are being reshaped by the rise of group purchasing organizations, tender-driven hospital contracts, and direct manufacturer relationships that prioritize long-term value and supply resilience.

From a buyer's perspective, technology selection is influenced by procedural complexity, setting capabilities, and reimbursement dynamics, leading to differentiated uptake across hospital operating rooms, ambulatory surgical centers, and specialty clinics. As a result, stakeholders must evaluate product portfolios not only on primary performance metrics but also on sterilization, storage, and in-procedure workflow compatibility. This introduction frames those dynamics and sets expectations for the deeper analysis to follow.

How advances in biomaterials, procedural migration to outpatient settings, and elevated regulatory requirements are reshaping market dynamics and clinical adoption

Over the past several years, transformative shifts have altered both the competitive and clinical landscapes for bone cements and surgical glues, driven by material science breakthroughs, procedural migration, and heightened regulatory scrutiny. Innovations in bioactive formulations have advanced from proof-of-concept to routine clinical evaluation, enabling materials that promote osteointegration and provide controlled resorption profiles. At the same time, improvements in delivery mechanisms, such as injectable and moldable formats, have expanded the range of minimally invasive and outpatient procedures that can reliably utilize these products.

Concurrently, there has been a steady movement of select procedures from inpatient settings to ambulatory surgical centers and specialty clinics, prompted by cost containment pressures and the drive to reduce hospital length of stay. This migration has pushed suppliers to refine packaging, sterilization, and handling features to suit lower-acuity settings where space and instrumentation differ from traditional OR environments. Transitioning procedural venues has also highlighted the importance of product ease-of-use and predictable performance under constrained time windows.

Regulatory expectations have intensified, particularly around safety labeling for antibiotic-loaded products and clinical data supporting long-term outcomes. As a result, companies are investing more heavily in clinical evidence generation and post-market surveillance. These combined shifts - material innovation, procedural migration, and regulatory focus - are creating new avenues for competitive differentiation while raising the bar for market entry and sustained commercial success.

Assessing how recent tariff measures have prompted strategic supply chain reconfiguration, sourcing regionalization, and commercial contracting shifts across the sector

The introduction of tariffs and trade policy changes in 2025 has created a measurable inflection point for supply chain strategies across the bone cement and glue sector. Import duties on intermediate inputs and finished devices have increased landed costs for manufacturers that rely on cross-border production of polymers, active additives, and packaging materials. In response, firms are reassessing sourcing strategies while accelerating regionalization of manufacturing capacity to reduce exposure to tariff volatility and to safeguard delivery timelines to key clinical customers.

As procurement teams adapt to higher input costs, there is stronger emphasis on value-based contracting and longer-term supply agreements that lock in pricing and service levels. This has intensified negotiations with distributors and group purchasing organizations, which are themselves recalibrating supplier portfolios to prioritize manufacturers with secure, near-shore production footprints. Consequently, companies without diversified manufacturing nodes or those dependent on single-source suppliers are under pressure to either secure alternative suppliers or to invest in localized production capabilities.

The tariff environment has also catalyzed innovation in packaging and product design to optimize transport efficiency and reduce weight- or volume-based duties. In parallel, firms are increasingly exploring toll manufacturing and licensing arrangements with regional partners to maintain market continuity while bypassing certain trade barriers. These strategic responses are not only tactical cost mitigations but also long-term decisions that influence competitive positioning, time-to-market for new formulations, and the resilience of supply chains amid shifting trade policies.

In-depth segmentation analysis reveals how product chemistry, clinical application, end-user settings, technology types, and distribution choices drive differentiated adoption pathways

Segmentation analysis reveals nuanced performance characteristics and adoption pathways that vary by product chemistry, clinical application, end-user setting, technology class, and distribution model. In terms of product type, the market encompasses acrylic bone cement and calcium phosphate cement; the acrylic segment is distinguished by antibiotic-loaded formulations and non-antibiotic variants that cater to infection control protocols and standard fixation needs respectively, while calcium phosphate alternatives are offered in injectable and moldable forms that respond to preferences for minimally invasive delivery or intraoperative shaping.

When viewed through the lens of application, clinical demand is distributed across craniomaxillofacial, dental, and orthopedic specialties. Craniomaxillofacial indications focus on reconstructive surgery and trauma repair with an emphasis on contour restoration and fixation; dental applications span implantology and restorative procedures where biocompatibility and handling impact osseointegration; orthopedic uses cover fracture fixation, joint replacement, and spinal surgery, each with distinct mechanical and biological performance imperatives that inform material selection.

End-user differentiation is significant: ambulatory surgical centers-comprising multi-specialty and orthopedic centers-prioritize quick-setting, easy-to-handle systems that align with accelerated throughput, whereas hospitals, both private and public institutions, demand versatility across complex procedures and compatibility with institutional purchasing protocols. Specialty clinics, including dental clinics and outpatient rehabilitation centers, require smaller package formats and user-friendly delivery systems tailored to high-volume, outpatient workflows.

Technology segmentation separates bioactive approaches from PMMA-based platforms. Bioactive technologies include calcium phosphate and calcium silicate variants designed to interact with host tissue and promote healing, while PMMA-based solutions present high-viscosity and low-viscosity options chosen for their mechanical stability and handling characteristics. From a distribution perspective, direct sales arrangements-built on OEM relationships and tender contracts-favor large institutional customers, distributors operate through group purchasing organizations and independent channels to reach a broader base, and online channels, comprising e-commerce platforms and manufacturer websites, are increasingly important for small-volume purchasers and quick replenishment. Together, these segmentation axes create a matrix of demand signals that manufacturers and suppliers must decode to align product development, marketing, and sales strategies effectively.

Regional dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific that influence adoption, regulatory priorities, and supply strategies

Regional dynamics materially influence both commercialization strategies and product development priorities. In the Americas, demand trends are shaped by a mature hospital infrastructure, expansive private hospital networks, and growing outpatient surgical capacity, which together create opportunities for both established PMMA-based products and emerging bioactive formulations that address infection control and osteointegration. The region's procurement sophistication encourages long-term supplier relationships and structured contracting mechanisms that reward evidence-backed performance and reliable supply chains.

In Europe, Middle East & Africa, regulatory harmonization and diverse healthcare models create a complex mosaic of adoption curves. Western European markets demand rigorous clinical data and often serve as launchpads for advanced bioactive materials, while markets in other parts of the region may emphasize cost-effectiveness and supply chain adaptability. Emerging markets within this region present growth potential driven by infrastructure investment and expanding access to surgical care, yet they require tailored distribution approaches and flexible pricing structures.

The Asia-Pacific region is characterized by a broad spectrum of market maturity, with high-volume centers in urban hubs adopting sophisticated materials and delivery systems, and peripheral settings prioritizing affordability and ease of use. Local manufacturing hubs and a thriving medtech innovation ecosystem in several countries are accelerating product localization and customization. Across all regions, supply chain resilience, regulatory alignment, and the ability to demonstrate clinical and economic value remain decisive factors for sustained adoption and market penetration.

Competitive landscape overview showing how incumbents, specialized innovators, and channel partners shape product differentiation and market access strategies

Competitive dynamics in the bone cement and surgical glue ecosystem are defined by a mixture of legacy manufacturers, specialty biomaterials firms, contract manufacturers, and innovative startups focused on next-generation bioactive chemistries. Established players benefit from entrenched relationships with large hospital systems, extensive commercial footprints, and experience with regulatory approvals across multiple jurisdictions. These incumbents often leverage scale to optimize manufacturing costs, invest in clinical evidence development, and offer bundled solutions that include instrumentation and training.

At the same time, midsized and emerging firms are differentiating through focused investments in niche technologies such as antibiotic-loaded cements with refined elution profiles, calcium phosphate systems designed for specific orthopedic niches, and high-precision delivery platforms that reduce intraoperative variability. Contract manufacturing organizations play an increasingly strategic role by enabling smaller innovators to scale production while managing quality systems and regulatory compliance.

Distribution partners, including national distributors and group purchasing organizations, act as gatekeepers to hospital formularies and ambulatory networks; their influence over purchasing decisions underscores the importance of channel strategies that balance direct sales relationships with broader distribution agreements. Partnerships and licensing arrangements are common as faster time-to-market and local regulatory alignment become priorities. Overall, competitive success hinges on a company's ability to demonstrate clinical differentiation, maintain supply continuity, and engage with stakeholders across procurement, clinical practice, and hospital leadership.

Actionable strategic priorities for manufacturers and suppliers to strengthen clinical differentiation, supply resilience, and commercial scalability in evolving care settings

Leaders in the bone cement and glue sector should adopt a multi-pronged strategy that addresses product excellence, supply chain resilience, and alignment with evolving clinical pathways. First, invest in clinical evidence programs that not only meet regulatory requirements but also generate real-world outcomes data demonstrating improvements in infection rates, implant stability, and patient recovery timelines. Such data supports differentiated value propositions during procurement negotiations and facilitates placement on hospital formularies and preferred vendor lists.

Second, diversify manufacturing and sourcing footprints to mitigate trade policy exposures and to ensure continuity of supply for critical hospital customers. This may include pursuing regional manufacturing partnerships, tolling agreements, or selective near-shoring to reduce lead times and tariff impacts. In tandem, optimize packaging and logistics to minimize transport costs and to meet the specific needs of ambulatory and outpatient settings where space and instrumentation differ from traditional operating theaters.

Third, refine commercial models to balance direct sales with distributor partnerships and digital channels. Direct engagement with large institutional buyers remains important for complex offerings, while distributors and online platforms can extend reach into smaller clinics and dental practices. Additionally, prioritize training and education programs that simplify product handling and demonstrate procedural efficiencies; clinicians value hands-on support and evidence-backed protocols that reduce intraoperative uncertainty.

Finally, pursue targeted R&D focused on user-centric product features such as adjustable setting times, improved radiopacity, and compatible delivery tools. Complement product development with strategic collaborations that accelerate clinical validation and regulatory approvals. Taken together, these actions will strengthen market positioning and create durable competitive advantage as clinical and procurement landscapes continue to evolve.

Robust mixed-methods research approach combining clinician interviews, supplier documentation analysis, and multi-source data triangulation to ensure actionable rigor

The research underpinning this analysis integrates qualitative and quantitative approaches to ensure comprehensive, evidence-based insights. Primary research consisted of structured interviews with clinicians across orthopedics, craniofacial surgery, and dentistry, procurement leaders from hospitals and ambulatory surgical centers, product managers from biomaterials companies, and distribution executives. These conversations provided direct perspectives on clinical performance expectations, procurement decision drivers, and operational constraints that shape product selection.

Secondary research involved systematic review of peer-reviewed literature, regulatory guidance documents, and publicly available clinical study summaries to validate material properties, performance claims, and safety profiles. In addition, supplier documentation, product IFUs, and clinical technique guides were analyzed to assess handling characteristics and usage protocols. Data triangulation combined insights from primary interviews with secondary sources to identify convergent themes and to reconcile conflicting viewpoints.

Analytical techniques included thematic coding of qualitative transcripts, comparative feature mapping across product types and technologies, and scenario analysis to evaluate the impact of supply chain disruptions and policy shifts. Quality assurance steps encompassed cross-validation with multiple interviewees, peer review of draft findings by subject matter experts, and adherence to transparent documentation standards for data sources and methodological assumptions. This robust methodology ensures the findings offer both practical relevance and analytical rigor for stakeholders seeking to inform strategy and operational planning.

Strategic closing perspective highlighting the convergence of clinical performance, procurement priorities, and supply resilience that will determine future market leaders

In closing, the bone cement and surgical adhesive market is transitioning toward solutions that blend reliable mechanical performance with biological activity and practical handling for diverse procedural settings. This evolution is driven by clinical demand for improved outcomes, by procurement pressures that emphasize value and supply resilience, and by regulatory expectations that prioritize patient safety and evidence-based practice. Stakeholders that align product development with clinical workflows and that invest in scalable, regionally resilient supply models will be best positioned to capture emerging opportunities.

As the sector advances, success will increasingly depend on the ability to translate material science into executable clinical advantages-reducing infection risk, enhancing fixation, and improving patient recovery-while simultaneously navigating the complexities of distribution and procurement. Collaborative approaches that engage clinicians early in design, partner with regional manufacturers or contract manufacturers to secure supply, and employ data-driven value propositions will differentiate suppliers in a competitive landscape. Overall, the outlook favors those who can combine demonstrable clinical value with operational excellence and strategic agility.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Surge in antibiotic-loaded PMMA bone cement formulations for targeted infection prevention in joint replacements
  • 5.2. Development of fully resorbable calcium phosphate-based bone glue enabling complete bone regeneration over time
  • 5.3. Integration of stem cell carriers into bioactive bone adhesive matrices to enhance localized tissue healing post surgery
  • 5.4. Adoption of dual-curing dental adhesives combining light activation and chemical setting for improved bonding durability
  • 5.5. Expansion of veterinary-grade bone cement applications in fracture repair surgeries for companion animals
  • 5.6. Use of 3D printing to create patient-specific bone cement molds for complex implant geometries in orthopedic procedures
  • 5.7. Collaboration between polymer chemists and orthopedic surgeons to develop thermosensitive injectable bone adhesives

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bone Cement & Glue Market, by Product Type

  • 8.1. Acrylic Bone Cement
    • 8.1.1. Antibiotic Loaded
    • 8.1.2. Non Antibiotic Loaded
  • 8.2. Calcium Phosphate Cement
    • 8.2.1. Injectable
    • 8.2.2. Moldable

9. Bone Cement & Glue Market, by Application

  • 9.1. Craniomaxillofacial
    • 9.1.1. Reconstructive Surgery
    • 9.1.2. Trauma Repair
  • 9.2. Dental
    • 9.2.1. Implantology
    • 9.2.2. Restorative
  • 9.3. Orthopedic
    • 9.3.1. Fracture Fixation
    • 9.3.2. Joint Replacement
    • 9.3.3. Spinal Surgery

10. Bone Cement & Glue Market, by End User

  • 10.1. Ambulatory Surgical Centers
    • 10.1.1. Multi Specialty
    • 10.1.2. Orthopedic Centers
  • 10.2. Hospitals
    • 10.2.1. Private Hospital
    • 10.2.2. Public Hospital
  • 10.3. Specialty Clinics
    • 10.3.1. Dental Clinics
    • 10.3.2. Outpatient Rehab

11. Bone Cement & Glue Market, by Technology

  • 11.1. Bioactive
    • 11.1.1. Calcium Phosphate
    • 11.1.2. Calcium Silicate
  • 11.2. PMMA Based
    • 11.2.1. High Viscosity
    • 11.2.2. Low Viscosity

12. Bone Cement & Glue Market, by Distribution Channel

  • 12.1. Direct Sales
    • 12.1.1. OEM Relationships
    • 12.1.2. Tender Contracts
  • 12.2. Distributors
    • 12.2.1. Group Purchasing Organizations
    • 12.2.2. Independent Distributors
  • 12.3. Online Channels
    • 12.3.1. E Commerce Platforms
    • 12.3.2. Manufacturer Website

13. Bone Cement & Glue Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bone Cement & Glue Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bone Cement & Glue Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Zimmer Biomet Holdings, Inc.
    • 16.3.2. Stryker Corporation
    • 16.3.3. DePuy Synthes, Inc.
    • 16.3.4. Heraeus Medical GmbH
    • 16.3.5. Smith & Nephew plc
    • 16.3.6. B. Braun Melsungen AG
    • 16.3.7. Medtronic plc
    • 16.3.8. TEI Biosciences, Inc.
    • 16.3.9. DJO Global, Inc.
    • 16.3.10. Paragon 28, LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL BONE CEMENT & GLUE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BONE CEMENT & GLUE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BONE CEMENT & GLUE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BONE CEMENT & GLUE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BONE CEMENT & GLUE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BONE CEMENT & GLUE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ANTIBIOTIC LOADED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ANTIBIOTIC LOADED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ANTIBIOTIC LOADED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ANTIBIOTIC LOADED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ANTIBIOTIC LOADED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ANTIBIOTIC LOADED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY NON ANTIBIOTIC LOADED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY NON ANTIBIOTIC LOADED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY NON ANTIBIOTIC LOADED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY NON ANTIBIOTIC LOADED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY NON ANTIBIOTIC LOADED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY NON ANTIBIOTIC LOADED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INJECTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MOLDABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MOLDABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MOLDABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MOLDABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MOLDABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MOLDABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TRAUMA REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TRAUMA REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TRAUMA REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TRAUMA REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TRAUMA REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TRAUMA REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY IMPLANTOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY IMPLANTOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY IMPLANTOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY IMPLANTOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY IMPLANTOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY IMPLANTOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RESTORATIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RESTORATIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RESTORATIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RESTORATIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RESTORATIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RESTORATIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY JOINT REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY JOINT REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY JOINT REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY JOINT REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPINAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPINAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPINAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPINAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MULTI SPECIALTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MULTI SPECIALTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MULTI SPECIALTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MULTI SPECIALTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MULTI SPECIALTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MULTI SPECIALTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OUTPATIENT REHAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OUTPATIENT REHAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OUTPATIENT REHAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OUTPATIENT REHAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OUTPATIENT REHAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OUTPATIENT REHAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM SILICATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM SILICATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM SILICATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM SILICATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM SILICATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM SILICATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HIGH VISCOSITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HIGH VISCOSITY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HIGH VISCOSITY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HIGH VISCOSITY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HIGH VISCOSITY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HIGH VISCOSITY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY LOW VISCOSITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY LOW VISCOSITY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY LOW VISCOSITY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY LOW VISCOSITY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY LOW VISCOSITY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY LOW VISCOSITY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OEM RELATIONSHIPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OEM RELATIONSHIPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OEM RELATIONSHIPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OEM RELATIONSHIPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OEM RELATIONSHIPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OEM RELATIONSHIPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TENDER CONTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TENDER CONTRACTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TENDER CONTRACTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TENDER CONTRACTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TENDER CONTRACTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TENDER CONTRACTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2025-2032 (USD MILLION)
  • TABLE 289. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2024 (USD MILLION)
  • TABLE 290. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2025-2032 (USD MILLION)
  • TABLE 291. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2024 (USD MILLION)
  • TABLE 294. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2025-2032 (USD MILLION)
  • TABLE 295. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 296. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2025-2032 (USD MILLION)
  • TABLE 297. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 298. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2025-2032 (USD MILLION)
  • TABLE 299. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 302. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 303. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 304. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 305. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 306. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 307. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 308. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 309. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2024 (USD MILLION)
  • TABLE 310. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2025-2032 (USD MILLION)
  • TABLE 311. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2024 (USD MILLION)
  • TABLE 312. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2025-2032 (USD MILLION)
  • TABLE 313. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 314. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 315. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 316. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 317. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 318. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 319. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 320. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 321. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 322. N